STOCKHOLDERS' EQUITY - Stock Options (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]
Outstanding at beginning of period (in shares)	1,045	867
Granted (in shares)	109	109
Exercised (in shares)	(31)	(8)
Forfeited (in shares)	(3)	0
Canceled (in shares)	0	0
Outstanding at end of period (in shares)	1,120	968
Exercisable at end of period (in shares)	743	676
Weighted Average Exercise Price
Outstanding at beginning of period (in dollars per share)	$ 99.82	$ 88.19
Granted (in dollars per share)	138.09	138.07
Exercised (in dollars per share)	79.27	63.52
Forfeited (in dollars per share)	128.27	0
Canceled (in dollars per share)	0	0
Outstanding at end of period (in dollars per share)	104.04	94.01
Exercisable at end of period (in dollars per share)	$ 88.07	$ 81.06
Aggregate intrinsic value, outstanding, beginning of period	$ 27,221	$ 69,711
Aggregate intrinsic value, outstanding, end of period	29,327	41,483
Aggregate intrinsic value, exercisable, end of period	$ 28,781	$ 37,594
Weighted average remaining contractual term, outstanding	6 years 6 months	6 years 7 months 6 days
Weighted average remaining contractual term, exercisable	5 years 2 months 12 days	5 years 7 months 6 days
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Weighted-average fair value of options granted (in dollars per share)	$ 40.91	$ 40.26
Total intrinsic value of stock options exercised	$ 1,584	$ 654
Stock options
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Dividend yield rate	0.50%	0.50%
Expected volatility rate	28.00%	31.00%
Risk-free interest rate	3.90%	2.00%
Expected term	4 years 9 months 18 days	4 years 10 months 24 days